🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

RT-CGM in Young Adults at Risk of DKA

RecruitingNAAges 18 Years - 25 YearsAllImperial College London
NCT04039763 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Pilot study to evaluate the effect of real time continuous glucose monitoring (RT-CGM) on young-adults with insulin-treated diabetes, who are defined as high risk due to suboptimal HbA1c (blood glucose control) or a history of hospital admissions for high blood glucoses. Hypothesis: RT-CGM provided to young adults with suboptimal blood glucose control, has a beneficial impact on HbA1c and hospital admissions for high blood glucoses. We will use data from this pilot work to inform a larger powered study to address this knowledge gap.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Adolescents and young adults aged 18-25 years * Insulin-treated diabetes \>12 months (on multiple daily injections or insulin pump therapy) * HbA1c \> 75 mmol/mol (9%) or 1 or more DKA admissions in the last 12 months or 1 or more admissions with uncontrolled blood glucose levels in the last 12 months. * Naïve to RT-CGM - except for short periods for use for diagnosis or monitoring purposes. * Use of prior flash glucose monitoring is permittable Exclusion Criteria: * Chronic kidney disease eGFR \<30ml/min * Pregnant or planning pregnancy * Breastfeeding * Have active malignancy or under investigation for malignancy * Severe visual impairment * Reduced manual dexterity * Unable to participate due to other factors, as assessed by the Chief Investigator
💊

What it tests

  • Dexcom G6
  • Self monitoring of blood glucose
📍

Where

1 site
Imperial College Clinical Research Facility
London, United Kingdom
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy